Related Experiment Videos
A monoclonal antibody against vimentin: characterization
Brain Research
|August 1, 1984
Summary
A new monoclonal antibody, RBA1, specifically targets the intermediate filament protein vimentin. This antibody shows promise for research in various tissues, including the brain and retina.
Area of Science:
- Neuroscience
- Cell Biology
- Immunology
Background:
- Intermediate filaments are crucial cytoskeletal components.
- Vimentin is a key intermediate filament protein found in various cell types.
- Specific antibodies are needed to study vimentin's distribution and function.
Purpose of the Study:
- To develop and characterize a novel monoclonal antibody targeting vimentin.
- To assess the specificity and binding patterns of the new antibody (RBA1).
Main Methods:
- Monoclonal antibody production using rat astrocytes.
- Immunofluorescence staining on tissue sections and cultured cells.
- Immunoblotting with purified vimentin and desmin.
- Competitive binding assays with purified vimentin.
Main Results:
- The monoclonal antibody RBA1 bound to intracellular filaments in cultured cells.
- RBA1 staining in tissue sections mirrored known vimentin distribution in brain, retina, and other tissues.
- Immunoblotting confirmed RBA1 binds vimentin but not desmin.
- RBA1 binding was blocked by purified vimentin, confirming specificity.
Conclusions:
- The developed monoclonal antibody RBA1 is specific for the intermediate filament protein vimentin.
- RBA1 is a valuable tool for studying vimentin in various cell types and tissues.
- The antibody's specificity was validated through multiple experimental approaches.